Grassley’s team has asked NAMI to disclose the specifics of its funding so that people with mental illness and their families, as well as the public and healthcare officials, can see for themselves how conflicted this advocacy group is.
The FDA expanded approval process for toxic drugs is unaffected by evidence uncovered by the US Justice Department showing the studies to be flawed, if not fraudulent.
April 14: the FDA announced that Coast IRB "has agreed to voluntarily halt some aspects of its clinical trial oversight operations due to serious concerns about the company’s ability to protect human subjects participating in clinical trials."
The results suggest that the truth may have escaped the usual exclusion criteria. Underlying the commercial success of the new antipsychotics is evidence (usually suppressed) showing that these drugs are both harmful and ineffective even for their approved use.
"The strategy of big companies when they are dealing with smaller opponents is to stretch the process, to overwhelm us until we are ready to accept whatever they want to offer."
It may come as a shock to some of you; but, Electroshock machines have never been tested for safety or efficacy.
Dr. Peter Slavin, president of Mass. General Hospital: "We don’t want our faculty being on the road as hired guns."
FDA officials who continue to run its powerful center for drug evaluation (CDER) have once again shown bad faith by appointing financially compromised doctors to the Psychopharmacologic Drugs Advisory Committee (PDAC) advisory panel.
The State of Florida has established a pre-approval requirement to protect preschool children on Medicaid from being exposed to the hazardous effects of antipsychotic drugs. That step has prompted "a seismic change" in doctors’ inappropriate prescribing of antipsychotics for preschool children: the number of prescriptions for this age group has…
"JAMA, your integrity is at stake." Chicago Tribune
